Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

SALL4 is a key transcription regulator in normal human hematopoiesis.

Gao C, Kong NR, Li A, Tatetu H, Ueno S, Yang Y, He J, Yang J, Ma Y, Kao GS, Tenen DG, Chai L.

Transfusion. 2013 May;53(5):1037-49. doi: 10.1111/j.1537-2995.2012.03888.x. Epub 2012 Aug 31.

2.

Sall4 overexpression blocks murine hematopoiesis in a dose-dependent manner.

Milanovich S, Peterson J, Allred J, Stelloh C, Rajasekaran K, Fisher J, Duncan SA, Malarkannan S, Rao S.

Exp Hematol. 2015 Jan;43(1):53-64.e1-8. doi: 10.1016/j.exphem.2014.09.004. Epub 2014 Sep 20.

3.

Role of SALL4 in hematopoiesis.

Yang J, Liao W, Ma Y.

Curr Opin Hematol. 2012 Jul;19(4):287-91. doi: 10.1097/MOH.0b013e328353c684. Review.

PMID:
22555391
4.

A SALL4/MLL/HOXA9 pathway in murine and human myeloid leukemogenesis.

Li A, Yang Y, Gao C, Lu J, Jeong HW, Liu BH, Tang P, Yao X, Neuberg D, Huang G, Tenen DG, Chai L.

J Clin Invest. 2013 Oct;123(10):4195-207. doi: 10.1172/JCI62891. Epub 2013 Sep 24.

5.

The transcriptome of the leukemogenic homeoprotein HOXA9 in human hematopoietic cells.

Dorsam ST, Ferrell CM, Dorsam GP, Derynck MK, Vijapurkar U, Khodabakhsh D, Pau B, Bernstein H, Haqq CM, Largman C, Lawrence HJ.

Blood. 2004 Mar 1;103(5):1676-84. Epub 2003 Nov 6.

6.

Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.

Bruns I, Steidl U, Fischer JC, Czibere A, Kobbe G, Raschke S, Singh R, Fenk R, Rosskopf M, Pechtel S, von Haeseler A, Wernet P, Tenen DG, Haas R, Kronenwett R.

Haematologica. 2008 Mar;93(3):347-55. doi: 10.3324/haematol.12081. Epub 2008 Feb 11.

7.

Dynamic HoxB4-regulatory network during embryonic stem cell differentiation to hematopoietic cells.

Fan R, Bonde S, Gao P, Sotomayor B, Chen C, Mouw T, Zavazava N, Tan K.

Blood. 2012 May 10;119(19):e139-47. doi: 10.1182/blood-2011-12-396754. Epub 2012 Mar 21.

8.
9.

Differential expression of the novel oncogene, SALL4, in lymphoma, plasma cell myeloma, and acute lymphoblastic leukemia.

Cui W, Kong NR, Ma Y, Amin HM, Lai R, Chai L.

Mod Pathol. 2006 Dec;19(12):1585-92. Epub 2006 Sep 22.

10.

Stem cell factor SALL4 represses the transcriptions of PTEN and SALL1 through an epigenetic repressor complex.

Lu J, Jeong HW, Kong N, Yang Y, Carroll J, Luo HR, Silberstein LE, Yupoma, Chai L.

PLoS One. 2009;4(5):e5577. doi: 10.1371/journal.pone.0005577. Epub 2009 May 18. Erratum in: PLoS One. 2009;4(7). doi: 10.1371/annotation/e0bd3a57-1ce4-4eaf-83de-034d39cac787. Jeong, Hawon [corrected to Jeong, Ha-Won].

11.

Activation of stem-cell specific genes by HOXA9 and HOXA10 homeodomain proteins in CD34+ human cord blood cells.

Ferrell CM, Dorsam ST, Ohta H, Humphries RK, Derynck MK, Haqq C, Largman C, Lawrence HJ.

Stem Cells. 2005 May;23(5):644-55.

12.
13.

Enhanced self-renewal of hematopoietic stem/progenitor cells mediated by the stem cell gene Sall4.

Yang J, Aguila JR, Alipio Z, Lai R, Fink LM, Ma Y.

J Hematol Oncol. 2011 Sep 23;4:38. doi: 10.1186/1756-8722-4-38.

14.

Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells.

Yang J, Chai L, Fowles TC, Alipio Z, Xu D, Fink LM, Ward DC, Ma Y.

Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19756-61. doi: 10.1073/pnas.0809321105. Epub 2008 Dec 5.

15.

HOXA9 promotes hematopoietic commitment of human embryonic stem cells.

Ramos-Mejía V, Navarro-Montero O, Ayllón V, Bueno C, Romero T, Real PJ, Menendez P.

Blood. 2014 Nov 13;124(20):3065-75. doi: 10.1182/blood-2014-03-558825. Epub 2014 Sep 3.

16.

Histone lysine-specific demethylase 1 (LSD1) protein is involved in Sal-like protein 4 (SALL4)-mediated transcriptional repression in hematopoietic stem cells.

Liu L, Souto J, Liao W, Jiang Y, Li Y, Nishinakamura R, Huang S, Rosengart T, Yang VW, Schuster M, Ma Y, Yang J.

J Biol Chem. 2013 Nov 29;288(48):34719-28. doi: 10.1074/jbc.M113.506568. Epub 2013 Oct 25.

17.

Transcription factor SCL/TAL1 mediates the phosphorylation of MEK/ERK pathway in umbilical cord blood CD34⁺ stem cells during hematopoietic differentiation.

Zhou RQ, Wu JH, Gong YP, Guo Y, Xing HY.

Blood Cells Mol Dis. 2014 Jun-Aug;53(1-2):39-46. doi: 10.1016/j.bcmd.2013.12.007. Epub 2014 Jan 7.

PMID:
24405580
18.

SALL4 is a robust stimulator for the expansion of hematopoietic stem cells.

Aguila JR, Liao W, Yang J, Avila C, Hagag N, Senzel L, Ma Y.

Blood. 2011 Jul 21;118(3):576-85. doi: 10.1182/blood-2011-01-333641. Epub 2011 May 20.

19.

Immune-related zinc finger gene ZFAT is an essential transcriptional regulator for hematopoietic differentiation in blood islands.

Tsunoda T, Takashima Y, Tanaka Y, Fujimoto T, Doi K, Hirose Y, Koyanagi M, Yoshida Y, Okamura T, Kuroki M, Sasazuki T, Shirasawa S.

Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14199-204. doi: 10.1073/pnas.1002494107. Epub 2010 Jul 26.

20.

SALL4, a stem cell factor, affects the side population by regulation of the ATP-binding cassette drug transport genes.

Jeong HW, Cui W, Yang Y, Lu J, He J, Li A, Song D, Guo Y, Liu BH, Chai L.

PLoS One. 2011 Apr 19;6(4):e18372. doi: 10.1371/journal.pone.0018372.

Supplemental Content

Support Center